Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.

Ferch U, Kloo B, Gewies A, Pfänder V, Düwel M, Peschel C, Krappmann D, Ruland J.

J Exp Med. 2009 Oct 26;206(11):2313-20. doi: 10.1084/jem.20091167. Epub 2009 Oct 19. Erratum in: J Exp Med. 2009 Nov 23;206(12):2851.

2.

Molecular pathways: targeting MALT1 paracaspase activity in lymphoma.

Fontán L, Melnick A.

Clin Cancer Res. 2013 Dec 15;19(24):6662-8. doi: 10.1158/1078-0432.CCR-12-3869. Epub 2013 Sep 4. Review.

3.

Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.

Juilland M, Thome M.

Curr Opin Hematol. 2016 Jul;23(4):402-9. doi: 10.1097/MOH.0000000000000257. Review.

4.

The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling.

Lin X, Wang D.

Semin Immunol. 2004 Dec;16(6):429-35. Review.

PMID:
15541657
5.

NF-kappaB signaling in lymphocytes: a new cast of characters.

Lucas PC, McAllister-Lucas LM, Nunez G.

J Cell Sci. 2004 Jan 1;117(Pt 1):31-9. Review.

6.

MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.

Afonina IS, Elton L, Carpentier I, Beyaert R.

FEBS J. 2015 Sep;282(17):3286-97. doi: 10.1111/febs.13325. Epub 2015 Jun 10. Review.

7.

Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies.

Pavan A, Spina M, Canzonieri V, Sansonno S, Toffoli G, De Re V.

Leuk Lymphoma. 2008 Nov;49(11):2048-58. doi: 10.1080/10428190802444176. Review.

PMID:
19021048
8.
9.

Determining the destiny of NF-kappa B after TCR ligation: it's CARMA1.

Bunnell SC.

Mol Interv. 2002 Oct;2(6):356-60, 338. Review.

PMID:
14993411
10.

Protease activity of MALT1: a mystery unravelled.

Kirchhofer D, Vucic D.

Biochem J. 2012 Jun 1;444(2):e3-5. doi: 10.1042/BJ20120414. Review.

PMID:
22574776
11.

Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity.

Pérez de Diego R, Sánchez-Ramón S, López-Collazo E, Martínez-Barricarte R, Cubillos-Zapata C, Ferreira Cerdán A, Casanova JL, Puel A.

J Allergy Clin Immunol. 2015 Nov;136(5):1139-49. doi: 10.1016/j.jaci.2015.06.031. Epub 2015 Aug 12. Review.

12.

Gene expression profiling of diffuse large B-cell lymphoma.

Rosenwald A, Staudt LM.

Leuk Lymphoma. 2003;44 Suppl 3:S41-7. Review.

PMID:
15202524
13.

Rewired NFκB signaling as a potentially actionable feature of activated B-cell-like diffuse large B-cell lymphoma.

Knittel G, Liedgens P, Korovkina D, Pallasch CP, Reinhardt HC.

Eur J Haematol. 2016 Dec;97(6):499-510. doi: 10.1111/ejh.12792. Epub 2016 Sep 8. Review.

PMID:
27526684
14.

The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.

Turvey SE, Durandy A, Fischer A, Fung SY, Geha RS, Gewies A, Giese T, Greil J, Keller B, McKinnon ML, Neven B, Rozmus J, Ruland J, Snow AL, Stepensky P, Warnatz K.

J Allergy Clin Immunol. 2014 Aug;134(2):276-84. doi: 10.1016/j.jaci.2014.06.015. Review.

15.

Malt1 and cIAP2-Malt1 as effectors of NF-kappaB activation: kissing cousins or distant relatives?

Kingeter LM, Schaefer BC.

Cell Signal. 2010 Jan;22(1):9-22. doi: 10.1016/j.cellsig.2009.09.033. Epub 2009 Sep 19. Review.

16.

The CBM signalosome: potential therapeutic target for aggressive lymphoma?

Yang C, David L, Qiao Q, Damko E, Wu H.

Cytokine Growth Factor Rev. 2014 Apr;25(2):175-83. doi: 10.1016/j.cytogfr.2013.12.008. Epub 2013 Dec 24. Review.

17.

MALT1 protease: a new therapeutic target in B lymphoma and beyond?

McAllister-Lucas LM, Baens M, Lucas PC.

Clin Cancer Res. 2011 Nov 1;17(21):6623-31. doi: 10.1158/1078-0432.CCR-11-0467. Epub 2011 Aug 25. Review.

18.

Lymphocyte signaling and activation by the CARMA1-BCL10-MALT1 signalosome.

Meininger I, Krappmann D.

Biol Chem. 2016 Dec 1;397(12):1315-1333. doi: 10.1515/hsz-2016-0216. Review.

PMID:
27420898
19.

Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1.

Thome M, Charton JE, Pelzer C, Hailfinger S.

Cold Spring Harb Perspect Biol. 2010 Sep;2(9):a003004. doi: 10.1101/cshperspect.a003004. Epub 2010 Aug 4. Review.

20.

B-cell receptor signaling in diffuse large B-cell lymphoma.

Young RM, Shaffer AL 3rd, Phelan JD, Staudt LM.

Semin Hematol. 2015 Apr;52(2):77-85. doi: 10.1053/j.seminhematol.2015.01.008. Epub 2015 Jan 15. Review.

Supplemental Content

Support Center